Literature DB >> 1545788

The HIP1 binding site is required for growth regulation of the dihydrofolate reductase gene promoter.

A L Means1, J E Slansky, S L McMahon, M W Knuth, P J Farnham.   

Abstract

The transcription rate of the dihydrofolate reductase (DHFR) gene increases at the G1/S boundary of the proliferative cell cycle. Through analysis of transiently and stably transfected NIH 3T3 cells, we have now demonstrated that DHFR promoter sequences extending from -270 to +20 are sufficient to confer similar regulation on a reporter gene. Mutation of a protein binding site that spans sequences from -16 to +11 in the DHFR promoter resulted in loss of the transcriptional increase at the G1/S boundary. Purification of an activity from HeLa nuclear extract that binds to this region enriched for a 180-kDa polypeptide (HIP1). Using this HIP1 preparation, we have identified specific positions within the binding site that are critical for efficient protein-DNA interactions. An analysis of association and dissociation rates suggests that bound HIP1 protein can exchange rapidly with free protein. This rapid exchange may facilitate the burst of transcriptional activity from the DHFR promoter at the G1/S boundary.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1545788      PMCID: PMC369537          DOI: 10.1128/mcb.12.3.1054-1063.1992

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  35 in total

1.  Human DNA polymerase alpha gene: sequences controlling expression in cycling and serum-stimulated cells.

Authors:  B E Pearson; H P Nasheuer; T S Wang
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

2.  Identification of a 70-base-pair cell cycle regulatory unit within the promoter of the human thymidine kinase gene and its interaction with cellular factors.

Authors:  Y K Kim; A S Lee
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

3.  The T/E1A-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding protein.

Authors:  T Chittenden; D M Livingston; W G Kaelin
Journal:  Cell       Date:  1991-06-14       Impact factor: 41.582

4.  The E2F transcription factor is a cellular target for the RB protein.

Authors:  S P Chellappan; S Hiebert; M Mudryj; J M Horowitz; J R Nevins
Journal:  Cell       Date:  1991-06-14       Impact factor: 41.582

5.  Cell cycle regulation of the E2F transcription factor involves an interaction with cyclin A.

Authors:  M Mudryj; S H Devoto; S W Hiebert; T Hunter; J Pines; J R Nevins
Journal:  Cell       Date:  1991-06-28       Impact factor: 41.582

6.  Inducible proteins binding to the murine thymidine kinase promoter in late G1/S phase.

Authors:  Q P Dou; J L Fridovich-Keil; A B Pardee
Journal:  Proc Natl Acad Sci U S A       Date:  1991-02-15       Impact factor: 11.205

7.  Rapid and efficient site-specific mutagenesis without phenotypic selection.

Authors:  T A Kunkel; J D Roberts; R A Zakour
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

8.  Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

Authors:  J D Dignam; R M Lebovitz; R G Roeder
Journal:  Nucleic Acids Res       Date:  1983-03-11       Impact factor: 16.971

9.  The retinoblastoma protein copurifies with E2F-I, an E1A-regulated inhibitor of the transcription factor E2F.

Authors:  S Bagchi; R Weinmann; P Raychaudhuri
Journal:  Cell       Date:  1991-06-14       Impact factor: 41.582

10.  The 5'-flanking region of the mouse thymidylate synthase gene is necessary but not sufficient for normal regulation in growth-stimulated cells.

Authors:  Y Li; D Li; K Osborn; L F Johnson
Journal:  Mol Cell Biol       Date:  1991-02       Impact factor: 4.272

View more
  75 in total

1.  Trypanosome spliced leader RNA genes contain the first identified RNA polymerase II gene promoter in these organisms.

Authors:  G Gilinger; V Bellofatto
Journal:  Nucleic Acids Res       Date:  2001-04-01       Impact factor: 16.971

2.  CDC25A phosphatase is a target of E2F and is required for efficient E2F-induced S phase.

Authors:  E Vigo; H Müller; E Prosperini; G Hateboer; P Cartwright; M C Moroni; K Helin
Journal:  Mol Cell Biol       Date:  1999-09       Impact factor: 4.272

3.  Regulation of endogenous E2F1 stability by the retinoblastoma family proteins.

Authors:  F Martelli; D M Livingston
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-16       Impact factor: 11.205

Review 4.  The E2F family: specific functions and overlapping interests.

Authors:  Claire Attwooll; Eros Lazzerini Denchi; Kristian Helin
Journal:  EMBO J       Date:  2004-11-11       Impact factor: 11.598

5.  Unbiased location analysis of E2F1-binding sites suggests a widespread role for E2F1 in the human genome.

Authors:  Mark Bieda; Xiaoqin Xu; Michael A Singer; Roland Green; Peggy J Farnham
Journal:  Genome Res       Date:  2006-04-10       Impact factor: 9.043

6.  The cell cycle-coupled expression of topoisomerase IIalpha during S phase is regulated by mRNA stability and is disrupted by heat shock or ionizing radiation.

Authors:  P C Goswami; J L Roti Roti; C R Hunt
Journal:  Mol Cell Biol       Date:  1996-04       Impact factor: 4.272

7.  Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation.

Authors:  M Xu; K A Sheppard; C Y Peng; A S Yee; H Piwnica-Worms
Journal:  Mol Cell Biol       Date:  1994-12       Impact factor: 4.272

8.  Transcriptional repression by the Rb-related protein p107.

Authors:  M Zamanian; N B La Thangue
Journal:  Mol Biol Cell       Date:  1993-04       Impact factor: 4.138

9.  Characterization of the deoxycytidine kinase promoter in human lymphoblast cell lines.

Authors:  E H Chen; E E Johnson; S M Vetter; B S Mitchell
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

10.  Structure and cell cycle-regulated transcription of the human cyclin A gene.

Authors:  B Henglein; X Chenivesse; J Wang; D Eick; C Bréchot
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-07       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.